Professor of Medicine, Mayo Medical School
Infectious Disease
Dr. Walter R. Wilson, MD
|
|
Give Review
Walter R. Wilson works in the field of Infectious Disease. He graduated from Baylor College of Medicine. Doctor Walter R. Wilson, MD is also published. He has 64 publications published. The lastest publication: "Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT): Scoring System to Guide Use of Echocardiography in the Management of Staphylococcus aureus Bacteremia.'
Publications
- Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT): Scoring System to Guide Use of Echocardiography in the Management of Staphylococcus aureus Bacteremia.
- Desulfovibrio legallii Prosthetic Shoulder Joint Infection and a Review of Antimicrobial Susceptibility and Clinical Characteristics of Desulfovibrio Infections.
- Reply to Fierer, Eisen and Denholm, Dauchy et al, and Nguyen and Jones.
- Impact of prior aspirin therapy on clinical manifestations of cardiovascular implantable electronic device infections.
- Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the infectious diseases society of america.
- Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the infectious diseases society of america.
- Predictors of Mortality in Patients With Cardiovascular Implantable Electronic Device Infections.
- Clinical practice. Infections of cardiovascular implantable electronic devices.
- Clinical Features and Outcomes of Cardiovascular Implantable Electronic Device Infections Due to Staphylococcal Species.
- Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota.
- Fungal prosthetic valve endocarditis: Mayo Clinic experience with a clinicopathological analysis.
- Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia.
- Propensity score analysis with a time-dependent intervention is an acceptable although not an optimal analytical approach when treatment selection bias and survivor bi...
- Conclusion about the association between valve surgery and mortality in an infective endocarditis cohort changed after adjusting for survivor bias.
- Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study.
- The role of valve surgery in infective endocarditis management: a systematic review of observational studies that included propensity score analysis.
- Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection.
- A systematic review of population-based studies of infective endocarditis.
- Risk factor analysis of permanent pacemaker infection.
- Infective endocarditis due to penicillin-resistant viridans group streptococci.
- Prospective study of bacteremia and complications With EUS FNA of rectal and perirectal lesions.
- Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections.
- Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis.
- Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis.
- Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota.
- Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study.
- The impact of valve surgery on 6-month mortality in left-sided infective endocarditis.
- ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and con...
- ACCF/AHA/CDC Conference report on emerging infectious diseases and biological terrorism threats. Task Force III: prevention and control of cardiovascular complications...
- Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia.
- Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans.
- Medical versus surgical management of Staphylococcus aureus prosthetic valve endocarditis.
- Infectious complications of percutaneous vascular closure devices.
- Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota.
- Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002.
- Nonvalvular cardiovascular device-related infections.
- In vitro activity of BAL9141 against clinical isolates of gram-negative bacteria.
- Lemierre syndrome variant: necrobacillosis associated with inferior vena cava thrombosis and pulmonary abscesses after trauma-induced leg abscess.
- Prospective risk assessment of bacteremia and other infectious complications in patients undergoing EUS-guided FNA.
- Haemophilus influenzae in respiratory tract infections in community-based clinical practice: therapy with gatifloxacin.
- Efficacy and safety of gatifloxacin in elderly outpatients with community-acquired pneumonia.
- Antibiotic treatment of infective endocarditis due to viridans streptococci, enterococci, and other streptococci.
- Euthermic endocarditis.
- Unique features of infective endocarditis in childhood.
- Technical modifications for improved results in total anomalous pulmonary venous drainage.
- Tracheostomy: a risk factor for mediastinitis after cardiac operation.
- A summary of the update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.
- Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawas...
- Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and...
- Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, an...
- Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections.
- Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections.
- Paraspinal abscess complicated by endocarditis following a facet joint injection.
- Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasa...
- Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fev...
- Task Force on Strategic Research Direction: Population/Outcomes/Epidemiology/Social Science Subgroup key science topics report.
- Comment on: The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials.
- Modifiers of symptomatic embolic risk in infective endocarditis.
- Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.
- Shuttleworthia satelles endocarditis: evidence of non-dental human disease.
- Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis.
- Prosthetic vascular graft infection: a risk factor analysis using a case-control study.
- Outcomes in patients with cardiovascular implantable electronic devices and bacteremia caused by Gram-positive cocci other than Staphylococcus aureus.
Doctors Specialties
- Infectious Disease Medicine
- Medical Microbiology
- Infectious Disease
Accepted Insurances
Education
-
Mayo School of Graduate Medical Education -
Baylor College of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1982684940 | |
| NPPES Provider LastName | WILSON | |
| NPPES Provider FirstName | WALTER | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 51.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1982684940 |
| Last Name Of The Provider | WILSON |
| First Name Of The Provider | WALTER |
| View All |
Similar Doctors
|
|
Dr. Katherine Y. Le, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert Orenstein, DO |
|
|
Dr. Nathan W. Cummins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark J. Enzler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sana Arif, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aaron J. Tande, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James M. Steckelberg, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ala S. Dababneh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pearlie P. Chong, MD |
|
|
Dr. Maria V. Dioverti Prono, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Theodore C. Bailey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neil W. Anderson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan J. Wright, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Omar M. Abu Saleh |